Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 12 of 12 results for platelet rich plasma

  1. Intradiscal Platelet Rich Plasma (PRP) Injections for Back Pain with Modic Type 1 Changes

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  2. Platelet-rich plasma injections for knee osteoarthritis (HTG497)

    Evidence-based recommendations on platelet-rich plasma injections for knee osteoarthritis in adults. This involves taking plasma from a small amount of the person’s own blood and injecting it into the knee.

    HealthTech guidance
    Published
    23 January 2019
    View recommendations

    Sections for HTG497

  3. Autologous blood injection for tendinopathy (HTG299)

    Evidence-based recommendations on autologous blood injection for tendinopathy. This involves supplying the tendon with growth factors that start the healing process.

    HealthTech guidance
    Published
    23 January 2013
    View recommendations

    Sections for HTG299

  4. Autologous blood injection for plantar fasciitis (HTG298)

    Evidence-based recommendations on autologous blood injection for plantar fasciitis. This involves supplying the connective tissue with growth factors that promote the healing process.

    HealthTech guidance
    Published
    23 January 2013
    View recommendations

    Sections for HTG298

  5. Further research on platelet-rich plasma injections for knee osteoarthritis should be in the form of randomised controlled trials with medium- to long-term follow-up, including validated measures of knee function and patient-reported outcomes.

    Recommendation ID IPG637/1 Question Further research on platelet-rich plasma injections for knee osteoarthritis should be in the form of...

    Research recommendation
    Published
    18 February 2019

  6. NICE encourages further research comparing autologous blood injections (with or without techniques to produce platelet-rich plasma) against established nonsurgical methods for managing tendinopathy. Trials should clearly describe patient selection (including the site of tendinopathy, duration of symptoms and any prior treatments) and document whether a 'dry needling' technique is used. Outcomes should include specific measures of pain, quality of life and function, and whether subsequent surgical intervention is needed.

    autologous blood injections (with or without techniques to produce platelet-rich plasma) against established nonsurgical methods for...

    Research recommendation
    Published
    9 June 2015

  7. Platelet-rich plasma injections for knee osteoarthritis (IPG637)

    We have moved interventional procedures guidance 637 to become HealthTech guidance 497. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  8. Platelet-rich plasma injections for osteoarthritis of the knee (IPG491)

    This guidance has been updated and replaced by NICE interventional procedures guidance 637.

    Withdrawn guidance

  9. Diabetic foot problems: prevention and management (NG19)

    This guideline covers preventing and managing foot problems in children, young people and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections.

    NICE guideline
    Last updated
    11 October 2019
    View recommendations

    Sections for NG19

  10. AposHealth for knee osteoarthritis (HTG671)

    Evidence-based recommendations on AposHealth for knee osteoarthritis.

    HealthTech guidance
    Published
    11 April 2023
    View recommendations

    Sections for HTG671

  11. 3C Patch for treating diabetic foot ulcers (HTG615)

    Evidence-based recommendations on 3C Patch for treating diabetic foot ulcers.

    HealthTech guidance
    Published
    7 March 2022
    View recommendations

    Sections for HTG615

  12. Methods for the development of NICE public health guidance (third edition) (PMG4)

    This manual describes the methods used by the Centre for Public Health Excellence (CPHE) in NICE to develop and update public health guidance